As of mid-September 2026, sustained low SARS-CoV-2 circulation underpins the 96.2% market-implied probability of no new coronavirus pandemic this year. WHO assessments through July describe the global public health risk as moderate, with weekly reported cases around 14,000, test positivity near 1.7%, and deaths averaging under 500 per week—sharp declines from prior years and far below pandemic thresholds. Ongoing surveillance shows no emergence of a novel, highly transmissible betacoronavirus capable of widespread severe disease, though a recently sequenced bat-derived strain with a furin cleavage site remains under study for zoonotic potential. High population immunity from prior infections and vaccination further limits escalation risk. A late-year spillover or variant shift with enhanced virulence could theoretically alter outcomes before December 31, but current epidemiological data and model trends indicate this remains improbable.